posted Oct 1, 2020, 12:09 AM by Rafidah binti Abd Rahim
[
updated Oct 1, 2020, 12:31 AM
]
No. | Drug Name | Decision | 1 | Apixaban 2.5mg Film Coated Tablet (Eliquis) | Agreed to add Neurologist as prescriber. | 2 | Apixaban 2.5mg Film Coated Tablet (Eliquis) | Agreed to add Nephrologist as prescriber. | 3 | Apixaban 5mg Film Coated Tablet (Eliquis) | Agreed to add Neurologist as prescriber. | 4 | Apixaban 5mg Film Coated Tablet (Eliquis) | Agreed to add Nephrologist as prescriber. | 5 | Bevacizumab 100mg Injection (MVASI) | Rejected as Special Formulary. | 6 | Bevacizumab 400mg Injection (MVASI) | Agreed to defer to next D&T meeting.
To get input from Ophthalmology team regarding MVASI use in the treatment of Age-related Macular Degeneration (AMD). | 7 | Daptomycin 500mg Injection (Cubicin) | Agreed to accept as Standard Formulary.
Limited to 8 patients per year.
Agreed to remove Tigecycline from the UMMC Formulary. | 8 | Desmopressin 4mcg Injection (Minirin) | Agreed to add Intensive Care Team as prescriber. | 9 | Dulaglutide 0.75mg Injection
(Trulicity) | Rejected as Special Formulary. Dulaglutide 1.5mg available in Special Formulary. | 10 | Dulaglutide 1.5mg Injection
(Trulicity)
| Agreed to add Cardiologist & Nephrologist (for patients with eGFR 15-30 only) as prescriber. | 11 | Erythromycin 500mg Injection | Agreed to accept as Standard Formulary. | 12 | Evolocumab 140mg Injection (Repatha) | Rejected as Special Formulary. Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis. | 13 | Guselkumab 100mg Injection (Tremfya) | Agreed to accept as Special Formulary. | 14 | Rivaroxaban 2.5mg Tablet (Xarelto) | Rejected to add in new strength with new indication and new prescriber. Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis. | 15 | Trastuzumab 600mg/5mL Inj (Herceptin SC) | Rejected as Special Formulary. Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis. | 16 | Ustekinumab 130mg/26mL Injection (Stelara)
| Rejected as Special Formulary. Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis. | 17 | Ustekinumab 90mg/1.0mL Injection (Stelara) | Rejected as Special Formulary. Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis. | 18 | Iron Hydroxide Sucrose Complex 100mg/5mL Injection
(Venofer) | Agreed to remove Venofer from the UMMC Formulary. Agreed to accept Monofer as Special Formulary. | 19 | Oxymetholone 50mg Tablet | Agreed to remove Oxymetholone 50mg tablet from the UMMC Formulary. | 20 | Sodium chloride 0.9% Eye Drops | Agreed to remove Sodium Chloride 0.9% Eye Drops from the UMMC Formulary. | 21 | Tigecycline 50mg Injection (Tygacil) | Agreed to remove Tigecycline from the UMMC Formulary.
Agreed to accept Daptomycin as Standard Formulary. | 22 | Deferasirox 125mg Dispersible Tablet
(EXJADE) | Rejected from procurement discontinuation.
EXJADE continues as Special Formulary. Pharmacy to monitor stock movement closely to prevent wastage due to expired stock. | 23 | Iron (III) Isomaltoside 500mg/5mL Injection
(Monofer) | Agreed to accept as Special Formulary.
Agreed to delete Venofer from the UMMC Formulary. |
Disclaimer: For new drug requests, physical stock availability will depend on procurement processes. Tender items will take about 3-6 months, non tender items will take about 1-3 months. Online formulary will be updated once physical stock is available or has depleted in UMMC Pharmacy.
|
|
posted Sep 30, 2020, 8:56 PM by Rafidah binti Abd Rahim
[
updated Sep 30, 2020, 8:59 PM
]
No. | Drug Name | Decision | 1 | Daclatasvir 60mg Tablet (Daclavir) | Agreed to accept as Standard Formulary. Subsidy for 30 patients per year. Pharmacy to request for additional funding from JPKA. Temporarily list in as Special Formulary while waiting for approval from JPKA. | 2 | Denosumab 60mg Injection
(Prolia) | Agreed to accept as Special Formulary.
First line: Alendronic acid.
Consider Denosumab if:
(1) eGFR < 35mL/min OR
(2) Treatment failure with oral bisphosphonates for at least 5 years or iv bisphosphonates for at least 3 years despite compliance. | 3 | Everolimus 2mg Tablet
(AFINITOR DISPERZ) | Rejected as Special Formulary.
Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis. | 4 | Everolimus 3mg Tablet
(AFINITOR DISPERZ) | Rejected as Special Formulary.
Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis. | 5 | Everolimus 5mg Tablet
(AFINITOR DISPERZ) | Rejected as Special Formulary.
Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis. | 6 | Remifentanyl 1mg Injection
(Ultiva) | Agreed to accept as Special Formulary. | 7 | Sirolimus 1mg Tablet (Rapamune) | Agreed to add Paediatric Onco - Hematologist and Paediatric Neurologist as prescribers. Rejected to subsidized all paediatric patients, instead, subsidy for 3 paediatric patients per year only (on yearly rotational basis). | 8 | Sofosbuvir 400mg Tablet
(VIRSO) | Agreed to accept as Standard Formulary. Subsidy for 30 patients per year. Pharmacy to request for additional funding from JPKA. Temporarily list in as Special Formulary while waiting for approval from JPKA. | 9 | Somatropin 6mg Injection
(Saizen Liquid) | Agreed to accept as Special Formulary. Agreed to remove Somatropin 8mg Injection (Saizen) from the UMMC formulary. | 10 | Request as Special Formulary, to replace Somatropin 8mg Injection (Saizen). | Rejected as Special Formulary.
Agreed to accept Somatropin 6mg Injection (Saizen Liquid) as Special Formulary. | 11 | Teriparatide 20mcg per dose Injection
(FORTEO) | Agreed to add Geriatrician as prescriber. | 12 | Zoledronic Acid 5mg Injection
(Aclasta) | Agreed to add Geriatrician as prescriber. | 13 | Dasabuvir 250mg Tablet
(Exviera) | Agreed to remove Dasabuvir 250mg Tablet (Exviera) from the UMMC Formulary.
Agreed to accept VIRSO and Daclavir as Standard Formulary in replace of Dasabuvir 250mg Tablet (Exviera). | 14 | Ombitasvir 12.5mg Paritaprevir 75mg Ritonavir 50mg Tablet
(Viekirax) | Agreed to remove Ombitasivir 12.5mg Paritaprevir 75mg Ritonavir 50mg Tablet (Viekirax) from the UMMC Formulary.
Accepted VIRSO and Daclavir as Standard Formulary in replace of Viekirax. | 15 | Paliperidone 3mg Extended-Release Tablet
(Invega) | Agreed to remove Paliperidone 3mg Extended-Release Tablet (Invega) from the UMMC Formulary.
| 16 | Somatropin 8mg Injection
(Saizen) | Agreed to remove Somatropin 8mg Injection (Saizen) from the UMMC Formulary.
Agreed to accept Somatropin 6mg Injection (Saizen Liquid) as Special Formulary in replace of Somatropin 8mg Injection (Saizen). |
Disclaimer: For new drug requests, physical stock availability will depend on procurement processes. Tender items will take about 3-6 months, non tender items will take about 1-3 months. Online formulary will be updated once physical stock is available or has depleted in UMMC Pharmacy.
|
|
posted May 20, 2020, 9:20 PM by Chong Ching Wern
[
updated May 20, 2020, 9:22 PM
]
|
No.
|
Drug Name
|
Decision
|
|
1
|
Anastrozole 1mg Tablet
|
Agreed to remove Anastrozole 1mg Tablet from Outpatient Pharmacy and maintain Anastrozole as Special Formulary (PharmUMMC Pharmacy only).
Agreed to accept Letrozole 2.5mg Tablet as Standard Formulary (Outpatient Pharmacy only).
|
|
2
|
Apixaban 2.5mg Tablet
(Eliquis)
|
Agreed to add Respiratory Medicine Specialist as prescriber.
|
|
3
|
Apixaban 5 mg Tablet
(Eliquis)
|
Agreed to add Respiratory Medicine Specialist as prescriber.
|
|
4
|
Ciprofloxacin 0.3% Fluocinolone Acetonide 0.025% Ear Drops
(Cetraxal Plus)
|
Rejected as Standard Formulary.
Availability of Ofloxacin 0.3% Ear Drop in the UMMC Formulary. Suggest to purchase from retail pharmacies if there is a need to use the combination.
|
|
5
|
Dapagliflozin 10mg Tablet
(Forxiga)
|
Agreed to add Cardiologist as prescriber.
|
|
6
|
Dupilumab 300mg/2mL Injection
(Dupixent)
|
Rejected as Special Formulary.
Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis.
|
|
7
|
Erenumab 70mg Injection
(Pasurta)
|
Rejected as Special Formulary.
Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis.
|
|
8
|
Escitalopram 10mg Tablet
|
Agreed to add Neurologist as prescriber.
|
|
9
|
Fondaparinux 7.5mg Injection
(Arixtra)
|
Rejected as Special Formulary.
There is no additional cost benefit compared to Fondaparinux 2.5mg Injection and Enoxaparin Injection.
|
|
10
|
Fusidic Acid 2% Cream
(Fucidin)
|
Rejected Fusidic Acid 2% Cream as Standard Formulary.
Availability of Mupirocin 2% Ointment in the UMMC Formulary. Suggest to purchase from retail pharmacies if there is a need to use.
Agreed to add Dermatologist as prescriber for Mupirocin 2% Ointment.
|
|
11
|
Glycopyrronium 50mcg Inhalation Powder Hard Capsule
(Seebri Breezhaler)
|
Agreed to accept as Special Formulary.
|
|
12
|
Human Normal Immunoglobulin 20% (2g/10mL) Solution for Subcutaneous Injection
(Hizentra)
|
Agreed to accept as Standard Formulary.
Use is limited to five patients a year.
|
|
13
|
Iron (III) Isomaltoside 500mg/5mL Injection
(Monofer)
|
Agreed to accept Iron (III) Isomaltoside 500mg/5mL Injection
(Monofer) as Special Formulary.
Agreed to remove Iron Hydroxide Sucrose Complex 100mg/5mL Injection (Venofer) from the UMMC formulary.
|
|
14
|
Ixekizumab 80mg Pre-filled Pen Injection
(Taltz)
|
Rejected as Special Formulary.
Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis.
|
|
15
|
Letrozole 2.5mg Tablet
(Femara)
|
Agreed to accept Letrozole 2.5mg Tablet as Standard Formulary (Outpatient Pharmacy only).
Agreed to remove Anastrozole 1mg Tablet from Outpatient Pharmacy and maintain Anastrozole 1mg Tablet as Special Formulary (PharmUMMC Pharmacy only).
|
|
16
|
Menotrophin 600units Injection
(Menopur Multidose)
|
Agreed to accept Menotrophin 600units Injection (Menopur Multidose) as Special Formulary.
Agreed to remove Menotrophin 75units Injection from the UMMC Formulary.
|
|
17
|
Mometasone Furoate Monohydrate 50mcg Nasal Spray
(Momate)
|
Agreed to accept Mometasone Furoate Monohydrate 50mcg Nasal Spray(Momate) as Standard Formulary.
Agreed to remove Budesonide 64mcg Nasal Spray from the UMMC Formulary.
|
|
18
|
Montelukast 10mg Tablet
|
Rejected to add Primary Care Specialist as prescriber, to maintain current restriction.
Primary Care Specialists are allowed to continue maintenance treatment initiated by Respiratory Medicine Specialists.
|
|
19
|
Mupirocin 2% Ointment
|
Agreed to add Dermatologist as prescriber.
|
|
20
|
Salmeterol 25mcg Fluticasone 125mcg Inhaler
|
Rejected to add Primary Care Specialist as prescriber, to maintain current restriction.
Primary Care Specialists are allowed to continue maintenance treatment initiated by Respiratory Medicine Specialists.
|
|
21
|
Salmeterol 25mcg Fluticasone 250mcg Inhaler
|
Rejected to add Primary Care Specialist as prescriber, to maintain current restriction.
Primary Care Specialists are allowed to continue maintenance treatment initiated by Respiratory Medicine Specialists.
|
|
22
|
Sirolimus 1mg Tablet
(Rapamune)
|
To be discussed again in the following D&T Meeting.
|
|
23
|
Venlafaxine 150mg XR Capsule
(Effexor XR)
|
Agreed to add Neurologist as prescriber.
|
|
24
|
Venlafaxine 37.5mg XR Capsule
(Effexor XR)
|
Agreed to add Neurologist as prescriber.
|
|
25
|
Venlafaxine 75mg XR Capsule
(Effexor XR)
|
Agreed to add Neurologist as prescriber.
|
|
26
|
Zonisamide 100mg Tablet
(Zonegran)
|
Agreed to accept as Standard Formulary.
|
|
27
|
Budesonide 64mcg Nasal Spray
|
Agreed to remove Budesonide 64mcg Nasal Spray from the UMMC Formulary.
Agreed to accept Mometasone Furoate Monohydrate 50mcg Nasal Spray(Momate) as Standard Formulary.
|
|
28
|
Iron Hydroxide Sucrose Complex 100mg/5mL Injection
(Venofer)
|
Agreed to remove Iron Hydroxide Sucrose Complex 100mg/5mL Injection (Venofer) from the UMMC formulary.
Agreed to accept Iron (III) Isomaltoside 500mg/5mL Injection
(Monofer) as Special Formulary.
|
|
29
|
Menotrophin 75units Injection
|
Agreed to remove Menotrophin 75units Injection from the UMMC Formulary.
Agreed to accept Menotrophin 600units Injection (Menopur Multidose) as Special Formulary.
|
Disclaimer:
For new drug requests, physical stock availability will depend on procurement processes.
Tender items will take about 3-6 months, non tender items will take about 1-3 months.
Online formulary will be updated once physical stock is available or has depleted in UMMC Pharmacy.
|
posted Oct 17, 2019, 8:31 PM by Chong Ching Wern
[
updated Oct 17, 2019, 11:56 PM
]
|
No.
|
Drug Name
|
Decision
|
|
1)
|
Amoxycillin 1000mg Tablet
(Ospamox)
|
Agreed to restore as Special Formulary.
Pharmacy to monitor one year usage.
|
|
2)
|
Dabigatran 110mg Capsule
(Pradaxa)
|
Agreed to add Neurologist as prescriber.
|
|
3)
|
Dabigatran 150mg Capsule
(Pradaxa)
|
Agreed to add Neurologist as prescriber.
|
|
4)
|
Dabigatran 75mg Capsule
(Pradaxa)
|
Agreed to add Neurologist as prescriber.
|
|
5)
|
Dulaglutide 1.5mg Injection
(Trulicity)
|
Agreed to accept Dulaglutide 1.5mg Injection
(Trulicity) as Special Formulary.
Agreed to delete Exenatide 2mg Injection (Bydureon) from the UMMC's formulary.
|
|
6)
|
EDTA 2% Eye Drops
|
Agreed to accept as Standard Formulary.
|
|
7)
|
Flecainide 100mg Tablet
(Tambocor)
|
Agreed to accept as Special Formulary.
|
|
8)
|
Insulin Degludec 70% Aspart 30% 300units/3mL Pen Injection
(Ryzodeg FlexTouch)
|
Rejected as Special Formulary.
Costs more than existing agents available in the UMMC's Formulary.
Available in UMSC for purchase and slow moving in UMSC.
|
|
9)
|
Levamisole 50mg Tablet
|
Agreed to accept as Standard Formulary.
|
|
10)
|
Mirabegron 25mg Prolonged-Release Tablet
(Betmiga)
|
Rejected as Standard Formulary, to maintain current status as Special Formulary.
|
|
11)
|
Mirabegron 50mg Prolonged-Release Tablet
(Betmiga)
|
Rejected as Standard Formulary, to maintain current status as Special Formulary.
|
|
12)
|
Quadrivalent Influenza Vaccine Injection, Split Virion, Inactivated
(VaxigripTetra)
|
Rejected to add Infectious Disease Specialist as prescriber, to maintain current restriction.
However, D&T Committee to propose to higher management for free annual vaccination for UMMC front liners as per Ministry of Health's indication.
|
|
13)
|
Saccharomyces boulardii CNCM I-745 250mg Capsule
(Bioflor)
|
Agreed to accept as Special Formulary in PharmSelatan.
Non-claimable.
|
|
14)
|
Saccharomyces boulardii CNCM I-745 250mg Powder for Oral Suspension
(Bioflor)
|
Agreed to accept as Special Formulary in PharmSelatan.
Non-claimable.
|
|
15)
|
Zonisamide 100mg Tablet
(Zonegran)
|
To invite Neurologist to the next D&T Meeting.
Suggest to remove one item to replace Zonisamide in Standard Formulary.
|
|
16)
|
Exenatide 2mg Injection
(Bydureon)
|
Agreed to delete Exenatide 2mg Injection (Bydureon) from the UMMC's formulary.
Reason: Accepted Dulaglutide 1.5mg Injection (Trulicity) as Special Formulary in D&T Bil. 03/2019.
|
|
17)
|
Propafenone 150mg Tablet
(Rytmonorm)
|
Agreed to delete from the UMMC's formulary.
Company discontinued distribution.
|
|
18)
|
Human Albumin 20% Injection Guideline
|
Agreed to accept proposed guideline.
|
|
19)
|
New Drug Request Form / SOP Modification
|
Agreed to proceed to propose to higher management for approval.
|
Disclaimer: For new drug request, physical stock availability will depend on procurement processes. Tender items will take about 3-6 months, non tender items will take about 1-3 months. Online formulary will be updated once physical stock is available or has depleted in UMMC Pharmacy. |
posted Jul 1, 2019, 6:06 PM by Chong Ching Wern
[
updated Jul 1, 2019, 6:16 PM
]
No. | Drug Name | Decision | 1) | Propafenone 150mg Tablet (Rytmonorm) | Agreed to accept as Special Formulary. | 2) | Flecainide 100mg Tablet (Tambocor) | Rejected as Special Formulary. Propafenone was accepted as Special Formulary for the same indication. | 3) | Deferasirox 90mg Tablet Deferasirox 360mg Tablet (Exjade) | Rejected as Standard Formulary. Suggest requestor to apply for extra funding from Jawatankuasa Pengurusan Kewangan dan Akaun (JPKA) for additional subsidy for five patients. | 4) | Flurbiprofen 4mg Patch (Acustop Cataplasma) | Rejected as Special Formulary. Availability of Diclofenac Gel and Ketoprofen Gel in the UMMC formulary and readily available in retail pharmacies. | 5) | Paroxetine 25mg CR Tablet (Seroxat) | Agree to delete from the UMMC formulary. To use generic option as first choice and was agreed by Psychiatric Team to switch to Apo-Paroxetine 20mg Tablet. | 6) | Montelukast 4mg Tablet (Singulair) | Agree to delete from the UMMC formulary. Slow movement and stocks were expired. Availability of Montelukast 4mg Granules in the UMMC formulary. | 7) | Telbivudine 600mg Tablet (Sebivo) | Agree to delete from the UMMC formulary. Company discontinuation. | 8) | Tinzaparin 4500units Injection (Innohep) | Agree to delete from the UMMC formulary. Company discontinuation. | 9) | Vitamin B (B1, B2, B6) Injection (Becolim) | Agree to delete from the UMMC formulary. Company discontinuation. Availability of Vitamin B and C Injection in the UMMC formulary. | 10) | Olodaterol 2.5mcg Inhalation Solution (Striverdi Respimat) | Agree to delete from the UMMC formulary. Company discontinuation. Availability of Spiriva Respimat and Spiolto Respimat in the UMMC formulary. | 11) | Oxybutinin 5mg Tablet (Voxytane) | Agree to delete from the UMMC formulary. Company discontinuation and was agreed by Peadiatric Surgery Team. | 12) | Dulaglutide 0.75mg Injection Dulaglutide 1.5mg Injection (Trulicity) | Rejected as Special Formulary. Dulaglutide’s Cardiovascular Outcome Trial (CVOT) published: Dulaglutide reduced cardiovascular outcomes in patients with or without previous cardiovascular disease. Costs more than Liraglutide 1.2mg once daily (with CVOT) and Exenatide 2mg once weekly. |
Disclaimer: For new drug request, physical stock availability will depend on procurement processes. Tender items will take about 3-6 months, non tender items will take about 1-3 months. Online formulary will be updated once physical stock is available or has depleted in UMMC Pharmacy. |
posted Apr 15, 2019, 11:48 PM by Chong Ching Wern
[
updated Apr 15, 2019, 11:48 PM
]
No. | Drug Name | Decision | 1) | Rufinamide 200mg Tablet (Inovelon) | Agreed to accept as Special Formulary (upon request). | 2) | Yellow Fever Vaccine Injection (Stamaril) | Agree to accept as Special Formulary (non-claimable). | 3) | Dapagliflozin 10mg Tablet (Forxiga) | Rejected to add Cardiologists as prescriber, to maintain current restriction. | 4) | Baricitinib 4mg Tablet (Olumiant) | Rejected as Special Formulary. Availability of Tofacitinib 5mg Tablet in the UMMC formulary. Suggest to apply to use using BUK on named patient basis. | 5) | Esomeprazole 20mg MUPS Tablet Esomeprazole 40mg MUPS Tablet Multiple Unit Pellet System (Nexium / Axiago) | Agree to accept as Standard Formulary to replace Omeprazole 2mg/mL Syrup. | 6) | Aripiprazole 400mg Prolonged Release Injection (Abilify Maintena) | Agree to accept as Special Formulary. | 7) | Liothyronine 100mcg Injection | Agree to delete from the UMMC formulary. Availability of Levothyroxine 200mcg Injection in the UMMC formulary. | 8) | Polymixin B Neomycin Hydrocortisone Ear Drops (Pocin) | Agree to delete from the UMMC formulary. Ototoxicity due to Neomycin component and removal from APPL contract list. | 9) | Varenicline 1mg Tablet (Champix) | Agree to delete from the UMMC formulary. Closure of Smoking Cessation Clinic, no prescriptions seen since 2016, slow movement and easily available in community pharmacies. | 10) | Varenicline 0.5mg Tablets x 11 Varenicline 1mg Tablets x 14 (Champix Starter Pack) | Agree to delete from the UMMC formulary. Closure of Smoking Cessation Clinic, no prescriptions seen since 2016, slow movement and easily available in community pharmacies. | 11) | Clodronate Sodium 800mg Tablet (Bonefos) | Agree to delete from the UMMC formulary. Company discontinuation. | 12) | Isotretinoin 10mg Capsule (Roaccutane) | Rejected to delete from the UMMC formulary, to maintain current restriction. | 13) | Isotretinoin 20mg Capsule (Roaccutane) | Rejected to delete from the UMMC formulary, to maintain current restriction. | 14) | Dulaglutide 0.75mg Injection Dulaglutide 1.5mg Injection (Trulicity) | Pending press release on cardiovascular safety outcome trial in June 2019. Costs more than existing agents available in the UMMC formulary. Suggest to review pricing. |
Disclaimer: For new drug request, physical stock availability will depend on procurement processes. Tender items will take about 3-6 months, non tender items will take about 1-3 months. Online formulary will be updated once physical stock is available or has depleted in UMMC Pharmacy. |
posted Jan 21, 2019, 6:55 PM by Chong Ching Wern
[
updated Jan 21, 2019, 6:55 PM
]
No.
|
Drug Name |
Decision |
1) |
Posaconazole 100mg M/R Tablet
(Noxafil)
|
Agreed to accept as Special Formulary to replace Posaconazole 40mg/mL Suspension.
|
2) |
Tenofovir Disoproxil Fumarate 300mg Emtricitabine 200mg Efavirenz 600mg Tablet
|
Agree to accept as Standard Formulary as an add-on to currently available antiretroviral agents in the UMMC's Formulary.
|
3) |
Brinzolamide 1% Brimonidine 0.2% Ophthalmic Suspension
(Simbrinza)
|
Agree to accept as Special Formulary.
|
4) |
Pimecrolimus 1% Cream
(Elidel) |
Agree to accept as Special Formulary for mild to moderate atopic dermatitis (Dermatologists only).
|
5) |
Aripiprazole 400mg Prolonged Release Injection
(Abilify Maintena)
|
Rejected as Special Formulary.
|
6) |
Citrate Solution (5L)
(Prismocitrate 18/0)
|
Agree to accept as Standard Formulary.
|
7) |
Rilpivirine 25mg Tablet
(Edurant) |
Rejected as Special Formulary.
Costs more than existing agents available in the UMMC's Formulary.
Available in UMSC for purchase. |
8) |
Liraglutide 1.8mg Injection
(Victoza) |
Rejected to add Cardiologists as prescribers, to maintain current restriction.
There are other existing oral anti-diabetes agents that Cardiologists can prescribe at a lower cost in the UMMC's Formulary.
|
9) |
Alteplase 50mg Injection
|
Acknowledged on the agreement of Pharmacy Department to increase to 30 sets per year (effective October 2018).
|
10) |
Nicotine 10mg Patch
(Nicorette)
|
Agree to delete from the UMMC's formulary.
Slow moving and stocks expired.
|
11) |
Nicotine 15mg Patch
(Nicorette)
|
Agree to delete from the UMMC's formulary.
Slow moving and stocks expired.
|
12) |
Nicotine 25mg Patch
(Nicorette)
|
Agree to delete from the UMMC's formulary.
Slow moving and stocks expired.
|
13) |
Afatinib 50mg Tablet
(Giotrif)
|
Agree to delete from the UMMC's formulary.
Company discontinuation.
Availability of 30mg and 40mg preparations in the UMMC's Formulary.
|
14) |
Dronedarone 400mg Tablet
(Multaq)
|
Agree to delete from the UMMC's formulary.
Company discontinuation.
|
15) |
Efavirenz 200mg Tablet
(Stocrin)
|
Agree to delete from the UMMC's formulary.
Company discontinuation.
Availability of Efavirenz 600mg Tablet preparation in the UMMC's Formulary.
|
16) |
Vardenafil 10mg Tablet
(Levitra)
|
Agree to delete from the UMMC's formulary.
Availability of alternatives in the UMMC's Formulary.
|
17) |
Vardenafil 20mg Tablet
(Levitra)
|
Agree to delete from the UMMC's formulary.
Availability of alternatives in the UMMC's Formulary.
|
18) |
Strontium Ranelate 2gm Powder
(Protaxos)
|
Agree to delete from the UMMC's formulary.
Company discontinuation.
|
19) |
Buprenorphine 10mg Patch
(Sovenor)
|
Agree to delete from the UMMC's formulary.
Company discontinuation.
Availability of Buprenorphine 5mg Patch preparation in the UMMC's Formulary.
|
20) |
Lamivudine 100mg Tablet
(Zeffix)
|
Agree to delete from the UMMC's formulary.
Slow moving and as per agreement by Gastroenterology Team.
Availability of alternatives in the UMMC's Formulary.
|
21) |
Adefovir 10mg Tablet
(Hepsera)
|
Agree to delete from the UMMC's formulary.
Slow moving and as per agreement by Gastroenterology Team.
Availability of alternatives in the UMMC's Formulary.
|
22) |
Isotretinoin 10mg Capsule
(Roaccutane)
|
Pharmacy to obtain consent from Dermatology Team before deleting from Special Formulary, to maintain current restriction.
|
23) |
Isotretinoin 20mg Capsule
(Roaccutane)
|
Pharmacy to obtain consent from Dermatology Team before deleting from Special Formulary, to maintain current restriction.
|
24) |
Interferon Alfa-2B 18 million units Injection
(Intron A)
|
Agree to delete from the UMMC's formulary.
Company discontinuation.
|
25) |
Interferon Alfa-2B 30 million units Injection
(Intron A)
|
Agree to delete from the UMMC's formulary.
Company discontinuation.
|
26) |
Abciximab 10mg/mL Injection
(Repro)
|
Agree to delete from the UMMC's formulary.
Company discontinuation.
|
27) |
Posaconazole 40mg/mL Suspension
(Noxafil)
|
Agree to delete from the UMMC's formulary.
Replaced by Posaconazole M/R Tablet.
|
Disclaimer:
For new drug request, physical stock availability will depend on procurement processes.
Tender items will take about 3-6 months, non tender items will take about 1-3 months.
Online formulary will be updated once physical stock is available or has depleted in UMMC Pharmacy. |
posted Oct 15, 2018, 12:58 AM by Chong Ching Wern
[
updated Oct 15, 2018, 1:14 AM
]
No.
|
Drug Name |
Decision |
1) |
Oxycodone Hydrochloride 10mg/mL Injection
(Oxynorm)
|
Rejected as UMMC Formulary.
Available in UMSC for purchase. |
2) |
Alirocumab 75mg Injection
Alirocumab 150mg Injection
(Praluent)
|
Rejected as Special Formulary.
Apply for use via BUK form on named patient basis.
|
3) |
Liraglutide 1.8mg Injection
(Victoza) |
To be discussed again in next D&T Meeting in December 2018. |
4) |
Linagliptin 5mg Tablet
(Trajenta) |
Agreed to to switch Sitagliptin (350 subsidy cards) to Linagliptin (350 subsidy cards) in Outpatient Pharmacy in the next tender due in 2020.
|
5) |
Macitentan 10mg Tablet
(Opsumit)
|
Agreed to accept Macitentan as Special Formulary to replace Bosentan 125mg Tablet (Tracleer).
|
6) |
Glycopyrronium 50mcg Inhalation Capsule
(Seebri Breezhaler)
|
Rejected as Special Formulary.
Available in UMSC for purchase. |
7) |
Celecoxib 200mg Capsule
(Celebrex) |
Agreed to supply Celecoxib to Orthopedics in-patients for acute pain management of fractures pre-operation and
post-operation up to maximum of 20 capsules in total.
|
8) |
Dapagliflozin 10mg Tablet
(Forxiga) |
Rejected to add new prescribers, to maintain current restriction.
|
9) |
Ketosteril Tablet
|
No new patients with immediate effect.
Pharmacy to continue supplying for existing 164 AP patients until 31 December 2019.
All patients to pay full cost and not claimable effective 1 January 2020.
|
10) |
Olodaterol 2.5mcg Inhalation Solution
(Striverdi Respimat)
|
Agreed to change from UMMC Formulary to Special Formulary.
|
11) |
Tacrolimus 0.5mg Capsule
Tacrolimus 1mg Capsule
(Prograf)
|
Rejected to add 20 subsidy cards for the indication of Lupus Nephritis, to maintain current restriction.
|
12) |
Vildagliptin 50mg Tablet
(Galvus)
|
Deleted.
|
13) |
Vildagliptin 50mg Metformin 850mg Tablet
Vildagliptin 50mg Metformin 1000mg Tablet
(GalvusMet)
|
Deleted.
|
14) |
Sitagliptin 100mg Tablet
(Januvia)
|
Deleted.
To be replaced by Linagliptin in the next tender once current tender ends in year 2020.
|
15) |
Sitagliptin 50mg Metformin 850mg Tablet
Sitagliptin 50mg Metformin 1000mg Tablet
(JanuMet)
|
Deleted.
|
16) |
Bosentan 125mg Tablet
(Tracleer)
|
Deleted.
|
17) |
Sertraline 50mg Tablet
(Zoloft)
|
Deleted.
|
18) |
Alendronate 70mg Cholecalciferol 5600iu Tablet (Fosamax Plus)
|
Deleted.
|
19) |
Etoposide 50mg Capsule
|
Deleted.
|
20) |
Granisetron 1mg Tablet
|
Deleted.
|
21) |
Pilocarpine 2% Eye Drop
Pilocarpine 4% Eye Drop
|
Deleted.
|
Disclaimer:
For new drug request, physical stock availability will depend on procurement processes.
Tender items will take about 3-6 months, non tender items will take about 1-3 months.
Online formulary will be updated once physical stock is available or has depleted in UMMC Pharmacy. |
posted Jun 24, 2018, 6:14 PM by Chong Ching Wern
[
updated Jun 24, 2018, 6:15 PM
]
No.
|
Drug Name |
Decision |
1) |
Fluticasone Propionate 125mcg Formoterol 5mcg
Inhaler
Fluticasone Propionate 250mcg Formoterol 10mcg
Inhaler
(Flutiform)
|
Accepted only one strength (Fluticasone Propionate 125mcg
Formoterol 5mcg Inhaler) as Special Formulary.
|
2) |
Benzydamine Hydrochloride 0.3% Spray
(Difflam Forte Throat Spray)
|
Rejected to add new prescribers, to maintain current
restrictions.
|
3) |
Ibuprofen 20mg/mL Oral Suspension
|
Accepted as Standard Formulary for paediatrics with Patent
Ductus Arteriosus (PDA) only. |
4) |
Desmopressin 200mcg Tablet
(Minirin) |
Agreed to add Paediatric Nephrologist as prescriber for
paediatrics with Primary Nocturnal Enuresis (PNE) only.
|
5) |
Dinoprostone 10mg Vaginal Delivery System
(Cervidil)
|
Rejected.
|
6) |
Rituximab 1400mg/11.7mL Solution for SC
Injection
(MabThera SC)
|
Accepted as Special Formulary (upon request).
|
7) |
Fentanyl 100mcg Sublingual Tablet
Fentanyl 200mcg Sublingual Tablet
Fentanyl 400mcg Sublingual Tablet
(Abstral)
|
Accepted as Special Formulary (200 and 400mcg
upon request).
|
8) |
Dolutegravir 50mg Tablet
(Tivicay) |
Agreed to have 40 subsidy cards.
Changed Post Exposure Prophylaxis (PEP) regimen to
Tenofovir / Emtricitabine + Dolutegravir.
|
9) |
Lopinavir 200mg Ritonavir 50mg Tablet
(Kaletra)
|
Agreed to change 20 Kaletra's subsidy cards to 20
Dolutegravir's subsidy cards.
Total Kaletra's subsidy cards will now be 130. (Refer Item 8)
|
10) |
Raltegravir 400mg Tablet
(Tivicay)
|
Agreed to replace all 20 Raltegravir's subsidy cards with 20
Dolutegravir's subsidy cards. (Refer Item 8)
|
11) |
Beclometasone 100mcg Formoterol 6mcg Inhaler
(Foster)
|
Deleted.
|
12) |
Nimodipine 30mg Tablet
(Nimotop)
|
Deleted.
|
13) |
Etoricoxib 60mg Tablet
(Arcoxia)
|
Deleted.
|
14) |
Esomeprazole 40mg Injection
(Nexium)
|
Deleted.
|
15) |
Lercanidipine 10mg Tablet
(Zanidip)
|
Deleted.
|
16) |
Asenapine 5mg Dispersible Wafer
(Saphris)
|
Deleted.
|
17) |
Pentosan Polysulfate 100mg Capsule
(Elmiron)
|
Deleted.
|
18) |
Amoxicillin 1000mg Tablet
(Ospamox)
|
Deleted.
|
19) |
Levocetirizine 5mg Tablet
(Xyzal)
|
Deleted.
|
20) |
Fluconazole 150mg Capsule
(Diflucan)
|
Deleted.
|
21) |
Carboxymethycellulose 0.5% Eye Drop
(Optive Advanced)
|
Deleted.
|
22) |
Ethinylestradiol 20mcg Desogestrel 150mcg Tablet
(Mercilon)
|
Deleted.
|
23) |
Chlorhexidine 0.015% Cetrimide 0.15% Irrigation
Solution (30mL)
|
Deleted.
|
24) |
Ambroxol 30mg Tablet
(Mucosolvan)
|
Deleted.
|
25) |
Paracetamol 500mg Injection
(Paracetamol Kabi)
|
Deleted.
|
Disclaimer:
For new drug request, physical stock availability will depend on procurement processes.
Tender items will take about 3-6 months, non tender items will take about 1-3 months.
Online formulary will be updated once physical stock is available or has depleted in UMMC Pharmacy. |
posted Jun 17, 2018, 7:26 PM by Chong Ching Wern
[
updated Jun 19, 2018, 7:51 PM
]
No.
|
Drug Name |
Decision |
1) |
Diacerein 50mg Capsules
(Artrodar)
|
Rejected.
|
2) |
Fosfomycin Trometamol 3gm Sachet
(Monurol)
|
Rejected.
|
3) |
Interferon Alfa 2A 135mcg and 180mcg Injection
(Pegasys)
|
Agreed to add Hematologist as prescriber with restrictions. |
4) |
Ketoprofen 30mg Transdermal Patch |
Rejected.
|
5) |
Cefuroxime 4mg/0.4mL Intracameral Injection
|
Accepted as Standard Formulary.
|
6) |
Sodium Picosulfate 10mg Magnesium Oxide 3.5gm
Anhydrous Citric Acid 12gm
(Pico-Salax)
|
Accepted as Standard Formulary for pediatrics only.
|
7) |
Naltrexone 50mg Tablet
|
Deleted.
|
8) |
Peg-Filgrastin 6mg/0.6mL Injection
(Peglasta)
|
Deleted.
|
9) |
Imipenem 500mg Cilastatin 500mg Injection
|
Deleted.
|
Disclaimer:
For new drug request, physical stock availability will depend on procurement processes.
Tender items will take about 3-6 months, non tender items will take about 1-3 months.
Online formulary will be updated once physical stock is available or has depleted in UMMC Pharmacy.
|
|
